Impact of cellular folate status and epidermal growth factor receptor expression on BCRP ABCG2-mediated resistance to gefitinib and erlotinib

LEMOS, C ; KATHMANN, I ; GIOVANNETTI, E ; CALHAU, C ; JANSEN, G ; PETERS, G. J

British journal of cancer, 2009-04, Vol.100 (7), p.1120-1127 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível